Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BHBK

Blue Hills Bancorp (BHBK) Stock Price, News & Analysis

Blue Hills Bancorp logo

About Blue Hills Bancorp Stock (NASDAQ:BHBK)

Advanced Chart

Key Stats

Today's Range
$23.54
$23.96
50-Day Range
$23.90
$23.90
52-Week Range
$20.00
$25.80
Volume
850,297 shs
Average Volume
167,026 shs
Market Capitalization
$643.15 million
P/E Ratio
23.20
Dividend Yield
3.35%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BHBK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Blue Hills Bancorp and its competitors with MarketBeat's FREE daily newsletter.

BHBK Stock News Headlines

Blue Hill says Territorial arguments based on ‘false premise’
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Blue Foundry Bancorp executive acquires $11k in stock
Best Bank Bonuses and Promotions of August 2024
Blue Hills Bancorp Inc
See More Headlines

BHBK Stock Analysis - Frequently Asked Questions

Blue Hills Bancorp, Inc. (NASDAQ:BHBK) released its earnings results on Wednesday, January, 23rd. The bank reported $0.28 EPS for the quarter, meeting the consensus estimate of $0.28. The bank earned $22.20 million during the quarter, compared to analyst estimates of $19.80 million. Blue Hills Bancorp had a trailing twelve-month return on equity of 6.48% and a net margin of 20.98%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Blue Hills Bancorp investors own include HarborOne Bancorp (HONE), PHH (PHH), Southern National Bancorp of Virginia (SONA), Independent Bank (INDB), JPMorgan Chase & Co. (JPM), Blueprint Medicines (BPMC) and Clementia Pharmaceuticals (CMTA).

Company Calendar

Last Earnings
1/23/2019
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Finance
Industry
State Commercial Banks
Sub-Industry
N/A
Current Symbol
NASDAQ:BHBK
CIK
1601545
Fax
N/A
Employees
236
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$1.03
Trailing P/E Ratio
23.20
Forward P/E Ratio
20.60
P/E Growth
N/A
Net Income
$24.56 million
Net Margins
20.98%
Pretax Margin
N/A
Return on Equity
6.48%
Return on Assets
0.94%

Debt

Debt-to-Equity Ratio
0.20
Current Ratio
1.02
Quick Ratio
1.02

Sales & Book Value

Annual Sales
$117.05 million
Price / Sales
5.49
Cash Flow
$1.07 per share
Price / Cash Flow
22.39
Book Value
$15.05 per share
Price / Book
1.59

Miscellaneous

Outstanding Shares
26,910,000
Free Float
N/A
Market Cap
$643.15 million
Optionable
Optionable
Beta
0.41
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:BHBK) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners